Recursion Pharmaceuticals, Inc. (RXRX)

Recursion Pharmaceuticals Revenue

Recursion Pharmaceuticals had revenue of $6.47M in the quarter ending March 31, 2026, a decrease of -56.11%. This brings the company's revenue in the last twelve months to $66.41M, up 11.07% year-over-year. In the year 2025, Recursion Pharmaceuticals had annual revenue of $74.68M with 26.92% growth.

• Revenue (ttm): $66.41M
• Revenue Growth: +11.07%
• P/S Ratio: 23.10
• Revenue / Employee: $110,680
• Employees: 600
• Market Cap: 1.53B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	74.68M	15.84M	26.92%
Dec 31, 2024	58.84M	14.26M	32.00%
Dec 31, 2023	44.58M	4.73M	11.88%
Dec 31, 2022	39.84M	29.67M	291.46%
Dec 31, 2021	10.18M	6.22M	156.89%
Dec 31, 2020	3.96M	1.64M	70.85%
Dec 31, 2019	2.32M	-	-

Data Source: Fiscal.ai Last updated: May 6, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 18, 2026

Data Sources Report a data error